Contacts
Schaffhauserstrasse 30 - 4332 Stein - Schweiz
Get in touch
Close

Contacts

Switzerland, Stein AG - 4332
Schaffhauserstrasse 30

+41 56 281 91 14

info@qps-engineering.ch

Category: News & Updates

copertina-data-10

AI and the Future of Work: Job Displacement Insights

Job Predictions for 2025: How AI is Replacing Us Up to 92 million jobs could be displaced globally by 2030, yet 78 million new opportunities may arise as AI evolves. 300 million jobs at risk, or about 9.1% of all jobs…

Read More
copertina-data-8

Emerging Trends in Biotech Manufacturing

Trends in Biotech Manufacturing: Continuous Processes and Flexible Multi-Product Plants Continuous manufacturing enhances production efficiency and product quality. Flexible multi-product plants allow for rapid adaptation to market demands. Technological innovations are crucial for maintaining competitiveness in the biotech sector. Economic implications…

Read More
copertina-data

Keyence Microscope Advancements in Imaging Technology

Keyence Microscopie News: Transforming Imaging in Science and Industry Keyence is leading the transformation of microscopy technology, enhancing research capabilities across various fields. The Keyence BZ-X1000 Fluorescence Microscope offers significant speed and resolution improvements. Keyence microscopes support advanced applications, including research…

Read More
copertina-data-10

Switzerland’s Pharmaceutical Industry as an Economic Powerhouse

The Pharmaceutical Industry: The Growth Engine of Switzerland Switzerland’s pharmaceutical industry contributes 5.4% to the national GDP. Approximately 46,000 individuals are directly employed in the sector, supporting 250,000 additional jobs. In 2023, pharmaceutical exports reached CHF 105.5 billion, representing 38.5% of…

Read More
copertina-data-9

Swiss Pharma Industry Faces Pressure from Trump Tariffs

Swiss Pharma Industry Particularly Vulnerable to Trump Tariffs Understanding Regulatory Changes: Stay informed about evolving tariffs and regulations. Diverse Supply Chains: Evaluate supply chains to minimize impacts from tariffs. Invest Wisely: Consider strategic investments in US operations to offset tariff impacts….

Read More
copertina-data-8

Switzerland’s Urgent Need for a Pharma Strategy

Does Switzerland Need a Strategy in Pharma? Switzerland’s pharmaceutical sector is crucial for its economy and global healthcare. Intensifying competition necessitates a proactive strategy to maintain leadership. The changing regulatory landscape requires harmonization with European standards. Innovation and sustainability are central…

Read More
copertina-data-5

The Impact of Robots on the Pharmaceutical Industry for 2025

Robots in the Pharmaceutical Environment: A Game Changer for 2025 Robotic systems are set to revolutionize drug discovery, enhancing speed and efficiency. Personalized medicine will leverage robotics for tailored treatments. Automation ensures compliance and safety, critical in the pharmaceutical sector. Robotic…

Read More
copertina-data-4

Explore Key CQV Trends in Pharma for 2025

CQV Trends in Pharma for 2025: The Future of Compliance and Quality Is Digital Embrace Digital Transformation: Keep abreast of the latest technologies in Pharma 4.0. Investing in AI, IoT, and data analytics can revolutionize your CQV processes. Invest in Automation…

Read More
copertina-data-2

Entwicklungen der Künstlichen Intelligenz in der Pharmazie

Was wird sich mit KI in der Pharmawelt rapide verändern? Die Integration von Künstlicher Intelligenz (KI) transformiert die Pharmaindustrie grundlegend. KI verbessert die Effizienz in Forschung, Marketing, Patientenfokus und Qualitätsmanagement. Herausforderungen wie regulatorische Hürden und ethische Standards sind bedeutend. Der menschliche…

Read More
copertina-data

Die Kontroverse um Galenica und “Medikamente für Nichts”

Warum die Galenica ein Medikament für «Nichts» schützen lässt Diskussion über den Patentschutz von „Medikamenten für Nichts“ Hintergrund zu Galenica und der pharmazeutischen Industrie Kritik an der Praxis des „Evergreening“ Ethische Überlegungen zum Patentschutz Wirtschaftliche Beweggründe für den Schutz von symptomlindernden…

Read More